MedPath

嘉应制药（湖南）有限公司

Ownership
-
Established
1995-09-13
Employees
-
Market Cap
-
Website
www.jinsa.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Diclofenac Potassium Capsules

Product Name
双氯芬酸钾胶囊
Approval Number
国药准字H20010549
Approval Date
Jun 24, 2024
NMPA

调经活血片

Approval Number
国药准字Z43020874
Approval Date
Jun 11, 2024
NMPA

接骨七厘片

Approval Number
国药准字Z43020061
Approval Date
May 29, 2024
NMPA

接骨七厘片

Approval Number
国药准字Z20003140
Approval Date
May 29, 2024
NMPA

连知解毒胶囊

Approval Number
国药准字Z20080061
Approval Date
Mar 7, 2023
NMPA

疏风活络片

Approval Number
国药准字Z20178009
Approval Date
Jul 29, 2022
NMPA

新生化颗粒

Approval Number
国药准字Z20063785
Approval Date
Dec 11, 2020
NMPA

益视颗粒

Approval Number
国药准字Z20064103
Approval Date
Dec 11, 2020
NMPA

Zolmitriptan Tablets

Product Name
托扶宁
Approval Number
国药准字H20061034
Approval Date
Nov 24, 2020
NMPA

接骨七厘胶囊

Approval Number
国药准字Z20053999
Approval Date
Jul 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.